Natural Products Insider is part of the divisionName Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Business Resources>Business Operations>Labs/Testing

ChromaDex Announces Top Line Results of its Second Human Clinical Trial

<p>ChromaDex Corp. (NASDAQ:CDXC announced today that the initial results of its second human clinical study of NIAGEN<sup>&reg;</sup> nicotinamide riboside chloride (NR) have confirmed NR significantly and sustainably raises the co-enzyme nicotinamide adenine dinucleotide (NAD+) in 140 healthy human volunteers over 8-weeks.</p>
TAGS: Healthy Living Ingredients Business Resources
Hide comments

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
NIST reference materials for supplement labs.jpg
Reference materials and lab certifications resolve industry-wide challenges
Sep 13, 2019
Hemp CBD needs ingredient testing and validation at every step.jpg
Transparency: The next generation
Sep 10, 2019
Good lab practices key to compliance.jpg
Ensuring good lab practices is key to compliance
Aug 30, 2019
Supplement testing labs collaborate to improve quality, safety.jpg
Supplement testing labs collaborate to improve quality, safety—podcast
Aug 23, 2019